The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 401–500 of 1,014
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 176
Koller, M., Schaer, B. A., Wolbers, M., Sticherling, C., Bucher, H. C., & Osswald, S. (2008) · Circulation · doi:10.1161/circulationaha.107.742155 · Cited by 141
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. G. (2006) · Circulation · doi:10.1161/circulationaha.106.655761 · Cited by 158
Biffi, M., Moschini, C., Bertini, M., Saporito, D., Ziacchi, M., Diemberger, I., Valzania, C., Domenichini, G., Cervi, E., Martignani, C., et al. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.836254 · Cited by 127
Sex Differences in Advanced Heart Failure Therapies
Hsich, E. (2019) · Circulation · doi:10.1161/circulationaha.118.037369 · Cited by 131
Key Issues in End Point Selection for Heart Failure Trials: Composite End Points
Neaton, J. D., Gray, G. W., Zuckerman, B. D., & Konstam, M. A. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.08.350 · Cited by 138
Catanzariti, D., Lunati, M., Landolina, M., Zanotto, G., LONARDI, G., Iacopino, S., Oliva, F. G., Perego, G. B., VARBARO, A., Denaro, A., et al. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02245.x · Cited by 130
UK guidelines for referral and assessment of adults for heart transplantation
Banner, N. R., Bonser, R. S., Clark, A., Clark, S. C., Cowburn, P. J., Gardner, R. S., Kalra, P. R., McDonagh, T., Rogers, C. A., Swan, L., et al. (2011) · Heart · doi:10.1136/heartjnl-2011-300048 · Cited by 130
“ELECTRICAL DEVICE TREATMENT Cardiac resynchronisation treatment (CRT) improves symptoms, reduces hospitalisations and improves survival in patients with class III/IV HF, LV ejection fraction #35% and a broad QRS complex.(22) 23 CRT does have a benefit in class IV HF(24) and may have a role in inotrope-treated patients…”
BackgroundElectrophysiological remodeling in heart failure
Wang, Y., & Hill, J. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.009 · Cited by 145
Beck, H., Boden, W. E., Patibandla, S., Kireyev, D., Gupta, V., Campagna, F., CAIN, M. E., & Marine, J. E. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.04.043 · Cited by 128
Woo, G. W., Petersen‐Stejskal, S., Johnson, J. W., CONTI, J. B., Aranda, J. A., & Curtis, A. B. (2005) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-005-6545-3 · Cited by 125
Chung, E. S., Katra, R. P., Ghio, S., Bax, J. J., Gerritse, B., Hilpisch, K. E., Peterson, B. J., Feldman, D. S., & Abraham, W. T. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq009 · Cited by 127
Epidemiology, Pathophysiology, Prognosis, and Treatment of Systolic and Diastolic Heart Failure
Aronow, W. S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000175289.87583.e5 · Cited by 138
Boogers, M. J., Chen, J., van Bommel, R. J., Borleffs, C. J. W., Dibbets‐Schneider, P., van der Hiel, B., Younis, I. A., Schalij, M. J., van der Wall, E. E., Garcia, E. V., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1621-z · Cited by 125
“CRT varies with up to one-third of patients with heart failure showing no response to CRT [5, 7].”
BackgroundPriori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, A. J., Elliot, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.01.001 · Cited by 160
Electromechanical Dyssynchrony and Resynchronization of the Failing Heart
Kirk, J. A., & Kass, D. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.300270 · Cited by 125
Self-citationLong-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation
Khadjooi, K., Foley, P. W. X., Chalil, S., Anthony, J., Smith, R. E. A., Frenneaux, M. P., & Leyva, F. (2008) · Heart · doi:10.1136/hrt.2007.129429 · Cited by 117
Mollema, S. A., Bleeker, G. B., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.071 · Cited by 118
“Of note, there was no significant effect at a QRS duration between 120 ms and 168 ms (2).”
BackgroundMethodResultInfluentialSchrage, B., Uijl, A., Benson, L., Westermann, D., Ståhlberg, M., Stolfo, D., Dahlström, U., Linde, C. M., Braunschweig, F., & Savarese, G. (2019) · Circulation · doi:10.1161/circulationaha.119.043012 · Cited by 121
Bleeker, G. B., Schalij, M. J., Nihoyannopoulos, P., Paul Steendijk, A., Molhoek, S. G., van Erven, L., Bootsma, M., Holman, E. R., van der Wall, E. E., & Bax, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.069 · Cited by 120
Pouleur, A., Knappe, D., Shah, A. M., Uno, H., Bourgoun, M., Foster, E., McNitt, S. A., Hall, W. J., Zaręba, W., Goldenberg, I., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr185 · Cited by 119
Leitlinien zur Herzschrittmachertherapie
Lemke, B., Nowak, B., & Pfeiffer, D. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0269-3 · Cited by 139
Hsing, J. M., Selzman, K. A., Leclercq, C., Pires, L. A., McLaughlin, M. G., McRae, S., Peterson, B. J., & ZIMETBAUM, P. J. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962605 · Cited by 118
Gold, M. R., Linde, C. M., Abraham, W. T., Gardiwal, A., & Daubert, J. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.12.031 · Cited by 119
Mechanisms of Enhanced β-Adrenergic Reserve From Cardiac Resynchronization Therapy
Chakir, K., Daya, S. K., Aiba, T., Tunin, R. S., Dimaano, V. L. J., Abraham, T. P., Schunke, K. J., Lai, E. W., Pacák, K., Zhu, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.774752 · Cited by 119
Self-citationGuidelines for the management of acute coronary syndromes 2006
(2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00304.x · Cited by 140
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.006 · Cited by 184
The evaluation and management of electrical storm.
Eifling, M., Razavi, M., & Massumi, A. (2011) · Europe PMC (PubMed Central) · Cited by 123
Goldstein, N. E., Mehta, D., Teitelbaum, E., Bradley, E. H., & Morrison, R. S. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0237-x · Cited by 118
Kadish, A. H., Bello, D. B., Finn, J. P., Bonow, R. O., Schaechter, A., Subacius, H. P., Albert, C. M., Daubert, J. P., Fonseca, C. G., & Goldberger, J. J. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01503.x · Cited by 120
The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta‐Analysis
Stavrakis, S., Lazzara, R., & Thadani, U. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02144.x · Cited by 117
Bogale, N., Witte, K. K., Priori, S. G., Cleland, J. G. F., Auricchio, A., Gadler, F., Gitt, A. K., Limbourg, T., Linde, C. M., & Dickstein, K. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr085 · Cited by 123
Egoavil, C. A., Ho, R. T., Greenspon, A. J., & Pavri, B. B. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.03.012 · Cited by 118
Sze, E. Y., Samad, Z. Z., Dunning, A. L., Campbell, K. B., Loring, Z., Atwater, B. D., Chiswell, K., KISSLO, J. A., Velazquez, E. J., & Daubert, J. P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.020 · Cited by 126
Tokodi, M., Schwertner, W. R., Kovács, A. D., Tősér, Z., Staub, L., Sárkány, A., Lakatos, B. K., Behon, A., Boros, A. M., Perge, P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz902 · Cited by 126
“Cardiac resynchronization therapy induces reverse left ventricular remodelling and improves outcomes in a certain subgroup of heart failure patients.(2,21) Despite these well-known beneficial effects, individual outcomes vary substantially.”
BackgroundZanon, F., Baracca, E., Pastore, G., Marcantoni, L., Fraccaro, C., Lanza, D., Picariello, C., Aggio, S., Roncon, L., Dell’Avvocata, F., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.034 · Cited by 116
Brugada, J., Delnoy, P. P. H. M., Brachmann, J., REYNOLDS, D. W., Padeletti, L., Noelker, G., Kantipudi, C., López, J. M. R., Dichtl, W., Borri-Brunetto, A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw526 · Cited by 128
“Of note, the clinical characteristics of patients in RESPONDCRT were comparable to those in other studies.(2,3) Majority of the patients were NYHA class III, with an even distribution of ischaemic and non-ischaemic cardiomyopathy.”
BackgroundResultMiller, W. L., Hartman, K. A., Burritt, M. F., Grill, D. E., & Jaffe, A. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.025 · Cited by 123
“i t d s d p t i r f p i c 2 H H atients with chronic heart failure (HF) manifest progresion of disease over time and an adverse prognosis (1,2) even n the absence of overt clinical events (3–5).”
BackgroundCardiac resynchronization therapy (CRT): Clinical trials, guidelines, and target populations
Linde, C. M., Ellenbogen, K. A., & McAlister, F. A. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.04.026 · Cited by 116
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines
Maisel, W. H., Hauser, R. G., Hammill, S. C., Hauser, R. G., Ellenbogen, K. A., Epstein, A. E., Hayes, D. L., Alpert, J. S., Berger, R. D., Curtis, A. B., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.024 · Cited by 114
AL‐KHATIB, S. M., PICCINI, J. P., KNIGHT, D., STEWART, M., CLAPP‐CHANNING, N., & SANDERS, G. D. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01659.x · Cited by 114
van der Boon, R. M. A., Mieghem, N. M. V., Theuns, D. A. M. J., Nuis, R.-J. M., Nauta, S. T., Serruys, P. W. J. C., Jordaens, L. J. L. M., van Domburg, R. T., & de Jaegere, P. P. T. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.11.115 · Cited by 118
“Also, subgroup analysis of randomized studies in heart failure patients have shown that QRScomplex duration and morphology constitute independent predictors of adverse long-term clinical outcome [12–15].”
BackgroundKutyifa, V., Stockburger, M. A., Daubert, J. P., Holmqvist, F., Olshansky, B., Schuger, C. D., Klein, H., Goldenberg, I., brenyo, A. J., McNitt, S. A., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001299 · Cited by 128
Update on heart failure management and future directions
Choi, H., Park, M., & Youn, J. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.428 · Cited by 126
“Conventional pharmacological treatment Pharmacological treatment of HF has been evolving through increased understanding of its pathophysiology and the development of new drugs (Table 1 [54-89], Fig.”
BackgroundPathobiology of Left Ventricular Dyssynchrony and Resynchronization
SPRAGG, D. D., & Kass, D. A. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.05.001 · Cited by 114
Self-citationCost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure
Nichol, G., Kaul, P., Huszti, E., & Bridges, J. F. P. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-5-200409070-00102 · Cited by 123
Dunlay, S. M., & Roger, V. L. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0107-7 · Cited by 111
“a greater benefit to CRT in women [73], the Comparison of Medical Therapy, Defibrillation, and Heart Failure (COMPANION) trial (randomized 1520 HF patients with an EF ≤35 % to CRT, CRT + ICD, or usual care) [74] and the Cardiac Resynchronization-HF (CARE-HF) trial (randomized 813 HF patients with EF <35 % to CRT or us…”
BackgroundEffect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure
Lancellotti, P., Melon, P. G., Sakalihasan, N., Waleffe, A., Dubois, C., Bertholet, M., & Piérard, L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.154 · Cited by 113
Hauser, R. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.077 · Cited by 121
Cleland, J. G. F., Calvert, M., Verboven, Y., & Freemantle, N. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.11.006 · Cited by 136
de Diagnóstico, G. D. T., & de Cardiología, T. D. L. I. C. C. D. L. S. E. (2005) · Revista Española de Cardiología · doi:10.1157/13078554 · Cited by 125
Shin, S., Hung, C., Uno, H., Hassanein, A. H., Verma, A. K., Bourgoun, M., Køber, L., Ghali, J. K., Velazquez, E. J., Califf, R. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.863795 · Cited by 112
Gold, M. R., Daubert, J., Abraham, W. T., Ghio, S., Sutton, M. S. J., Hudnall, J. H., Cerkvenik, J., & Linde, C. M. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.11.014 · Cited by 116
Ryanodine receptor-mediated arrhythmias and sudden cardiac death
BLAYNEY, L. M., & Lai, F. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.006 · Cited by 123
Potential proarrhythmic effect of biventricular pacing: Fact or myth?
Shukla, G., Chaudhry, G. M., Orlov, M. V., Hoffmeister, P. S., & Haffajee, C. I. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.05.019 · Cited by 109
Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., Mehra, M. R., O’Connor, C. M., REYNOLDS, D. W., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.03.030 · Cited by 119
Marijon, É., Leclercq, C., Narayanan, K., Bovéda, S., Klug, D., Lacaze-Gadonneix, J., Defaye, P., Jacob, S., Piot, O., Deharo, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv455 · Cited by 110
Pappone, C., Ćalović, Ž., Vicedomini, G., Cuko, A., McSpadden, L. C., Ryu, K., Jordan, C. D., Romano, E., Baldi, M., Saviano, M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.02.008 · Cited by 109
Gold, M. R., Niazi, I. K., GIUDICI, M. C., Leman, R. B., Sturdivant, J. L., KIM, M. H., Yu, Y., Ding, J., & Waggoner, A. D. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00770.x · Cited by 109
Mack, M. J., Abraham, W. T., Lindenfeld, J., Bolling, S. F., Feldman, T. E., Grayburn, P. A., Kapadia, S. R., McCarthy, P. M., Lim, D. S., Udelson, J. E., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.07.021 · Cited by 115
Pires, L. A., Abraham, W. T., Young, J. B., & Johnson, K. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.024 · Cited by 110
Prediction and prevention of sudden cardiac death in heart failure
Lane, R., Cowie, M., & CHOW, A. W. C. (2005) · Heart · doi:10.1136/hrt.2003.025254 · Cited by 119
MANAGEMENT OF END STAGE HEART FAILURE
Friedrich, E. B., & Böhm, M. (2007) · Heart · doi:10.1136/hrt.2006.098814 · Cited by 130
Adelstein, E. C., & Saba, S. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.069 · Cited by 110
“In conclusion, patients with RBBB undergoing CRT had low rates of symptomatic and echocardiographic response, and their survival free from orthotopic heart transplantation or ventricular assist device placement was significantly worse than in patients with LBBB. Patients with conventionally paced QRS experienced an in…”
MethodResultInfluentialLinde, C. M., Abraham, W. T., Gold, M. R., & Daubert, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.055 · Cited by 109
Potential of resveratrol in the treatment of heart failure
Raj, P., Louis, X. L., Thandapilly, S. J., Movahed, A., Zieroth, S. R., & Netticadan, T. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.12.011 · Cited by 118
“…heart failure patients includes screening for candidacy for primary prevention implantable defibrillators and cardiac resynchronization which have additive morbidity and mortality benefits (Moss et al., 2002, 2009; Bardy et al., 2005; Tang et al., 2010; Bristow et al., 2004; Cleland et al., 2005).”
BackgroundHorwich, T. B., Foster, E., Marco, T. D., Tseng, Z. H., & Saxon, L. A. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.04279.x · Cited by 114
Self-citationTreating the right patient at the right time: Access to heart failure care
Ross, H. J., Howlett, J. G., Arnold, J. M. O., Liu, P., O’Neill, B. J., Brophy, J. M., Simpson, C. S., Sholdice, M. M., Knudtson, M. L., Ross, D. B., et al. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70290-2 · Cited by 107
Kalscheur, M. M., Kipp, R. T., Tattersall, M. C., Mei, C., Buhr, K. A., DeMets, D. L., Field, M. E., Eckhardt, L. L., & Page, C. D. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005499 · Cited by 131
Self-citationRemme, W. J., McMurray, J. J. V., Hobbs, R. F., Solal, A. C., Lopez-Sendon, J. L., Boccanelli, A., Zannad, F. M., Rauch, B. H., Keukelaar, K., Macarie, C., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn196 · Cited by 105
Ferreira, J. P., Duarte, K., Graves, T., Zile, M. R., Abraham, W. T., Weaver, F. A., Lindenfeld, J. M., & Zannad, F. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.936 · Cited by 109
Epidemiology and stratification of risk for sudden cardiac death
Podrid, P. J., & Myerburg, R. J. (2009) · Clinical Cardiology · doi:10.1002/clc.4960281303 · Cited by 120
Whinnett, Z. I., Davies, J. E., Willson, K., CHOW, A. W. C., Foale, R. A., Davies, D. W., Hughes, A. D., Francis, D. P., & Mayet, J. (2006) · EP Europace · doi:10.1093/europace/eul017 · Cited by 106
“In this study, we have found that systemic haemodynamic effects of changes in AV delay in patients with cardiac resynchronization are immediately detectable by continuous non-invasive haemodynamic monitoring, with even small changes in AV delay causing significant immediate effects on systolic BP.”
BackgroundInfluentialBYRNE, M. J., Helm, R. H., Daya, S. K., Osman, N. F., Halperin, H. R., Berger, R. D., Kass, D. A., & Lardo, A. C. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.011 · Cited by 105
Self-citationBecker, M., Hoffmann, R., Schmitz, F., Hundemer, A., Kühl, H. P., SCHAUERTE, P. N., Kelm, M., & Franke, A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.07.019 · Cited by 107
Ypenburg, C., Schalij, M. J., Bleeker, G. B., Paul Steendijk, A., Boersma, E. H., Dibbets‐Schneider, P., Stokkel, M. P. M., van der Wall, E. E., & Bax, J. J. (2006) · PubMed · Cited by 105
Dupont, M., Rickard, J., Baranowski, B. J., Varma, N., Dresing, T., Gabi, A., Finucan, M., Müllens, W., Wilkoff, B. L., & Tang, W. H. W. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.059 · Cited by 106
Cardiac conduction is required to preserve cardiac chamber morphology
Chi, N. C., Bussen, M., Brand‐Arzamendi, K., Ding, C., Olgin, J. E., Shaw, R. M., Martin, G. R., & Stainier, D. Y. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909432107 · Cited by 108
Gras, D., GUPTA, M. S., Boulogne, E., Guzzo, L., & Abraham, W. T. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02294.x · Cited by 104
Characterization of super-response to cardiac resynchronization therapy
Rickard, J., Kumbhani, D. J., Popović, Z., Verhaert, D., Manne, M. B., Sraow, D. I., Baranowski, B. J., Martin, D. O., Lindsay, B. D., Grimm, R. A., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.04.005 · Cited by 103
Boerrigter, G., Costello‐Boerrigter, L. C., Abraham, W. T., Sutton, M. G. S. J., Heublein, D. M., Kruger, K. M., Hill, M. R. S., McCullough, P. A., & Burnett, J. C. J. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.03.009 · Cited by 105
Hara, H., Oyenuga, O. A., Tanaka, H., ADELSTEIN, E. C., Onishi, T., McNamara, D. M., SCHWARTZMAN, D. S., Saba, S., & Gorcsan, J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs013 · Cited by 103
“Right bundle branch block patients who lacked dyssynchrony had the least improvement in ESV or EF following CRT.”
BackgroundInfluentialErmiş, C., Seutter, R., Zhu, A. X., Benditt, L. C., VanHeel, L., Sakaguchi, S., Lurie, K. G., Lü, F., & Benditt, D. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.067 · Cited by 102
Antiarrhythmic Effect of Reverse Ventricular Remodeling Induced by Cardiac Resynchronization Therapy
Biase, L. D., Gasparini, M., Lunati, M., Santini, M., Landolina, M., Boriani, G., Curnis, A., Bocchiardo, M., Vincenti, A., Denaro, A., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.043 · Cited by 103
Feeny, A. K., Rickard, J., Patel, D. R., Toro, S., Trulock, K., Park, C. J., Labarbera, M., Varma, N., Niebauer, M., Sinha, S., et al. (2019) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007316 · Cited by 65
Nayak, H. M., Verdino, R. J., Russo, A. M., Gerstenfeld, E. P., Hsia, H. H., Lin, D., Dixit, S., Cooper, J. M., Callans, D. J., & Marchlinski, F. E. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01122.x · Cited by 102
Ethnic and racial disparities in cardiac resynchronization therapy
Farmer, S. A., Kirkpatrick, J. N., Heidenreich, P. A., Curtis, J. P., Wang, Y., & Groeneveld, P. W. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.12.018 · Cited by 102
Becker, M., Franke, A., Breithardt, O. A., Ocklenburg, C., Kaminski, T., Kramann, R., Knackstedt, C., Stellbrink, C., Hanrath, P., SCHAUERTE, P. N., et al. (2007) · Heart · doi:10.1136/hrt.2006.095612 · Cited by 105
Stevenson, W. G., Hernandez, A. F., Carson, P. E., Fang, J. C.-T., Katz, S. D., Spertus, J. A., Sweitzer, N. K., Tang, W. H. W., Albert, N. M., Butler, J., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.12.004 · Cited by 107
Self-citationRenal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis
Cleland, J. G. F., Carubelli, V., Castiello, T., Yassin, A., Pellicori, P., & Antony, R. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9306-2 · Cited by 111
QRS Duration or QRS Morphology
Poole, J. E., Singh, J. P., & Birgersdotter-Green, U. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.039 · Cited by 101
Gasparini, M., Bocchiardo, M., Lunati, M., Ravazzi, P. A., Santini, M., Zardini, M., Signorelli, S., PASSARDI, M., & Klersy, C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.04.004 · Cited by 103
Peterson, P. N., Greiner, M. A., Qualls, L. G., Al‐Khatib, S. M., Curtis, J. P., Fonarow, G. C., Hammill, S. C., Heidenreich, P. A., Hammill, B. G., Piccini, J. P., et al. (2013) · JAMA · doi:10.1001/jama.2013.8641 · Cited by 100
DeSimone, C. V., Friedman, P. A., Noheria, A., Patel, N. A., DeSimone, D. C., Bdeir, S., Aakre, C. A., Vaidya, V. R., Slusser, J. P., Hodge, D. O., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003540 · Cited by 100
Shun-Shin, M. J., Zheng, S. L., Cole, G. D., Howard, J. P., Whinnett, Z. I., & Francis, D. P. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx028 · Cited by 106
Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly
Yung, D., BIRNIE, D. H., Dorian, P., Healey, J. S., Simpson, C. S., Crystal, E., Krahn, A. D., Khaykin, Y., CAMERON, D. A., Chen, Z., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001442 · Cited by 99
Iroquois Homeodomain Transcription Factors in Heart Development and Function
Kim, K.-H., Rosen, A., Bruneau, B. G., Hui, C., & Backx, P. H. (2012) · Circulation Research · doi:10.1161/circresaha.112.265041 · Cited by 103
Kutyifa, V., Kloppe, A., Zaręba, W., Solomon, S. D., McNitt, S. A., Polonsky, S., Barsheshet, A., Merkely, B. P., Lemke, B., Nagy, V. K., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.051 · Cited by 100
Neelagaru, S. B., Sánchez, J., Lau, S. K., Greenberg, S. M., RAVAL, N. Y., WORLEY, S. J., Kalman, J., Merliss, A. D., Krueger, S., Wood, M. A., et al. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.06.031 · Cited by 101
Self-citationThe European CRT Survey: 1 year (9–15 months) follow-up results
Bogale, N., Priori, S., Cleland, J. G. F., Brugada, J., Linde, C., Auricchio, A., van Veldhuisen, D. J., Limbourg, T., Gitt, A., Gras, D., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr158 · Cited by 98
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.